Login / Signup

Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?

Amer M ZeidanMaximilian StahlMichelle DeVeauxSmith GiriScott HuntingtonNikolai A PodoltsevRong WangXiaomei MaAmy J DavidoffSteven D Gore
Published in: Blood cancer journal (2018)
Keyphrases
  • acute myeloid leukemia
  • smoking cessation
  • free survival
  • hiv testing
  • bone marrow
  • hepatitis c virus
  • human immunodeficiency virus
  • replacement therapy